title: Experience with obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Oki
authors.forename: Amanda
authors.initials: A
authors.lastname: Copeland
authors.forename: Fredrick
authors.initials: F
authors.lastname: Hagemeister
authors.forename: Luis E
authors.initials: LE
authors.lastname: Fayad
authors.forename: Michelle
authors.initials: M
authors.lastname: Fanale
authors.forename: Jorge
authors.initials: J
authors.lastname: Romaguera
authors.forename: Anas
authors.initials: A
authors.lastname: Younes
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D007211:Indoles; D008297:Male; D008875:Middle Aged; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors*; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D019253:Proto-Oncogene Proteins c-bcl-2; D011758:Pyrroles; C520962:obatoclax